3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Weights and Measures: new trials by email Literature Review of Weights and Measures trials Research Report on Weights and Measures
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) Ustekinumab Dose Based on BSA and Body Weight, Matching Placebo - Colitis, Ulcerative | Phase 3 | Completed | Janssen Research & Development, LLC | 112 | 2021-03-17 | 2026-10-20 |
| Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies Privigen® 100mg/ml at the dose of 2g/kg of body weight, NaCl 0,9% - Primary Sjögren's Syndrome Painful Sensory Neuropathies | Phase 3 | Completed | University Hospital, Strasbourg, France | 24 | 2019-06-19 | 2025-08-08 |
| Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in Obese Patients: Towards New Phenotypic Markers for an Optimized Care Pathway fMRI, Indirect calorimetry, Bioimpedance - Obesity | Phase 2 / Phase 3 | Completed | Rennes University Hospital | 47 | 2018-04-26 | 2023-08-01 |
Colitis, Ulcerative (1) · Food Addiction (1) · Obesity (1)
Janssen Research & Development, LLC (1) · Rennes University Hospital (1) · University Hospital, Strasbourg, France (1)
France (2) · Belgium (1) · Germany (1) · Hungary (1) · Israel (1) · Japan (1) · Poland (1) · Russia (1) · United Kingdom (1) · United States (1)
David Val-Laillet, MSc, PhD, HDR (1) · Jacques-Eric Jacques-Eric, MD (1)
2019 (1), 2023 (1)